Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Distribute ZyGEM's DNA Extraction Products

NEW YORK (GenomeWeb News) – New Zealand-based ZyGEM today said that lab supply and distribution firm VWR International will exclusively distribute the firm’s DNA extraction products to the life science research, forensics, diagnostics, agriculture, and animal health markets in North and South America.
 
ZyGEM’s technology uses a thermophilic enzyme to extract DNA from samples using a single closed-tube system. The firm said that its approach can significantly reduce the time and cost of DNA extractions while simplifying laboratory workflow, minimizing error, reducing the risk of contamination.
 
“We believe this technology is transforming and expect that greater access to our DNA extraction kits will facilitate the growing use of genetic analyses in diverse applications,” ZyGEM CEO Paul Kinnon said in a statement.
 
Financial terms of the deal were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.